[
  {
    "sample_id": 0,
    "image_file": "test_files/dataset_image_0.png",
    "metadata": {
      "format": "TABLE",
      "documentQuality": "PHOTO"
    },
    "ground_truth_markdown": "\"| Rank | Nation          | Gold | Silver | Bronze | Total |\\n|------|-----------------|------|--------|--------|-------|\\n| 1    | **Australia** (AUS)   | 2    | 1      | 0      | 3     |\\n| 2    | **Italy** (ITA)      | 1    | 1      | 1      | 3     |\\n| 3    | **Germany** (EUA)    | 1    | 0      | 1      | 2     |\\n| 4    | **Soviet Union** (URS) | 1    | 0      | 0      | 1     |\\n| 5    | **Switzerland** (SUI) | 0    | 2      | 1      | 3     |\\n| 6    | **United States** (USA) | 0   | 1      | 0      | 1     |\\n| 7    | **Great Britain** (GBR) | 0   | 0      | 1      | 1     |\\n| 7    | **France** (FRA)   | 0    | 0      | 1      | 1     |\"",
    "ocr_success": true,
    "markdown_prediction": "```markdown\n| Rank | Nation           | **Gold** | **Silver** | **Bronze** | **Total** |\n|------|------------------|----------|------------|------------|-----------|\n| 1    | Australia (AUS)  | 2        | 1          | 0          | 3         |\n| 2    | Italy (ITA)      | 1        | 1          | 1          | 3         |\n| 3    | Germany (EUA)    | 1        | 0          | 1          | 2         |\n| 4    | Soviet Union (URS) | 1      | 0          | 0          | 1         |\n| 5    | Switzerland (SUI) | 0       | 2          | 1          | 3         |\n| 6    | United States (USA) | 0     | 1          | 0          | 1         |\n| 7    | Great Britain (GBR) | 0     | 0          | 1          | 1         |\n| 7    | France (FRA)     | 0        | 0          | 1          | 1         |\n```"
  },
  {
    "sample_id": 1,
    "image_file": "test_files/dataset_image_1.png",
    "metadata": {
      "format": "CHART",
      "documentQuality": "CLEAN"
    },
    "ground_truth_markdown": "\"# Company structure\\n\\nBD is structured to serve customers by providing unique solutions. The data below represents the company structure for FY 2019.\\n\\n## Revenue by geography\\n\\n(millions of dollars)\\n\\nUnited States (including Puerto Rico)\\n$9,730\\n\\nEurope\\n$3,359\\n\\nGreater Asia (including Japan and Asia Pacific)\\n$2,726\\n\\nOther (including Latin America, Canada and EMA [which includes the Commonwealth of Independent States, Middle East and Africa])\\n$1,476\\n\\n## Revenue by segment\\n\\n(billions of dollars)\\n\\n$9.1\\nBD Medical\\n\\n$4.3\\nBD Life Sciences\\n\\n$3.9\\nBD Interventional\\n\\n<table>\\n    <tr>\\n        <td colspan=\\\"2\\\" style=\\\"text-align:center;\\\">$17.3</td>\\n    </tr>\\n    <tr>\\n        <td colspan=\\\"2\\\" style=\\\"text-align:center;\\\">Total BD revenue</td>\\n    </tr>\\n    <tr>\\n        <td>Diabetes Care</td>\\n        <td>$1.1</td>\\n    </tr>\\n    <tr>\\n        <td>Medication Management Solutions</td>\\n        <td>$2.6</td>\\n    </tr>\\n    <tr>\\n        <td>Medication Delivery Solutions</td>\\n        <td>$3.9</td>\\n    </tr>\\n    <tr>\\n        <td>Urology and Critical Care</td>\\n        <td>$1.1</td>\\n    </tr>\\n    <tr>\\n        <td>Peripheral Intervention</td>\\n        <td>$1.4</td>\\n    </tr>\\n    <tr>\\n        <td>Surgery</td>\\n        <td>$1.4</td>\\n    </tr>\\n    <tr>\\n        <td>Biosciences</td>\\n        <td>$1.2</td>\\n    </tr>\\n    <tr>\\n        <td>Diagnostic Systems</td>\\n        <td>$1.5</td>\\n    </tr>\\n    <tr>\\n        <td>Preanalytical Systems</td>\\n        <td>$1.6</td>\\n    </tr>\\n    <tr>\\n        <td>Pharmaceutical Systems</td>\\n        <td>$1.5</td>\\n    </tr>\\n</table>\\n\\nValues in this exhibit reflect rounded numbers in billions and include Bard.\\n\\nGRI disclosures: 102-6, 102-7\\n<page_number>6</page_number>\\n\"",
    "ocr_success": true,
    "markdown_prediction": "# Company structure\n\nBD is structured to serve customers by providing unique solutions. The data below represents the company structure for FY 2019.\n\n## Revenue by geography\n(millions of dollars)\n\n- **United States** (including Puerto Rico)\n  - **$9,730**\n- **Europe**\n  - **$3,359**\n- **Greater Asia** (including Japan and Asia Pacific)\n  - **$2,726**\n- **Other** (including Latin America, Canada and EMA (which includes the Commonwealth of Independent States, Middle East and Africa))\n  - **$1,476**\n\n## Revenue by segment\n(billions of dollars)\n\n- **$9.1**  \n  BD Medical\n- **$4.3**  \n  BD Life Sciences\n- **$3.9**  \n  BD Interventional\n\nValues in this exhibit reflect rounded numbers in billions and include Bard.\n\n**$17.3**  \nTotal BD revenue\n\n- **$2.6**  \n  Medication Management Solutions\n- **$3.9**  \n  Medication Delivery Solutions\n- **$1.1**  \n  Diabetes Care\n- **$1.1**  \n  Urology and Critical Care\n- **$1.4**  \n  Peripheral Intervention\n- **$1.2**  \n  Biosciences\n- **$1.5**  \n  Diagnostic Systems\n- **$1.6**  \n  Preanalytical Systems\n- **$1.5**  \n  Pharmaceutical Systems\n- **Surgery**\n\n**GRI disclosures: 102-6, 102-7**"
  }
]